Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.
GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.
GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.
Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.
Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.
As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.
Rhea-AI Summary
GE HealthCare Technologies Inc. (GEHC) announced the pricing of a secondary underwritten public offering of 13,000,000 shares of its common stock at $82.25 per share. General Electric Company (GE) is expected to exchange the GEHC shares for indebtedness held by Morgan Stanley. The offering, led by top financial institutions, is expected to close on February 21, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
-
Rhea-AI Summary
GE HealthCare Technologies Inc. (Nasdaq: GEHC) has announced a secondary underwritten public offering of 13,000,000 shares of its common stock. The company will not receive any proceeds from the sale, as General Electric Company is expected to exchange the shares for indebtedness held by Morgan Stanley. The offering includes an option for underwriters to purchase additional shares, with major financial institutions serving as lead book-running managers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
-
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) announces CFO Jay Saccaro's participation in key investor conferences, providing access to the events for stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
Rhea-AI Summary
GE HealthCare (GEHC) and MedQuest Associates announced a three-year collaboration to optimize multi-site outpatient imaging networks for success. The partnership aims to provide innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest to deliver excellence in patient care. MedQuest will leverage GE HealthCare's AI-enabled digital capabilities to enhance care delivery and product line development in outpatient imaging. The collaboration is expected to boost operational efficiency, expand access, and improve patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
-
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) reported strong financial performance for the fourth quarter and full year 2023, with revenue growth of 5% and 7% year-over-year respectively. The company also provided 2024 financial guidance, demonstrating progress toward medium-term financial targets. However, net income margin and adjusted EBIT margin saw declines compared to the prior year. Cash flow from operating activities and free cash flow also experienced slight decreases. Despite these declines, the company invested over $1 billion in R&D for future growth and made significant strides in innovation and market position through strategic acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.65%
Tags
-
News
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) reported strong financial performance in the fourth quarter and full year of 2023. Revenue growth was 5% year-over-year in Q4 and 7% for the full year. Net income margin was 7.7% in Q4 and 8% for the full year. Adjusted EBIT margin was 16.1% in Q4 and 15.1% for the full year. Cash flow from operating activities was $1.1 billion in Q4 and $2.1 billion for the full year. The company provided 2024 financial guidance, demonstrating progress toward medium-term financial targets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.65%
Tags
Rhea-AI Summary
GE HealthCare has received FDA clearance for an expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients ≥34 weeks. The Novii+ noninvasively measures and displays fetal heart rate, maternal heart rate, and uterine activity, providing patient comfort and mobility in the hospital. The wireless design enables mobility and freedom for mothers, and studies have shown that it may help decrease the length of labor. Novii+ is an expanded indication from the Novii Maternal and Fetal Monitoring Solution that utilizes an updated algorithm to improve reliability and accuracy. It can be used for both antepartum and intrapartum pregnant patients 34 weeks and greater, which extends usage before the previously defined use of 37 weeks and greater of pregnancy. The expanded indication is based on data submitted to the FDA to determine Novii+ Wireless Patch Solution’s equivalence to doppler fetal heart rate, tocodynamometer uterine activity, and pulse oximetry maternal heart rate devices for preterm patients (≥34 weeks) in terms of accuracy and reliability. It is a first-of-its-kind patch-based antepartum and intrapartum monitoring solution for preterm patients (≥34 weeks). The Novii+ Wireless Patch Solution will be available to customers in the United States later this year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
-
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. The new platform maintains high signal fidelity, reduces environmental noise, and offers advanced analytics for the diagnosis and treatment of cardiac arrhythmias. The prevalence of AFib is projected to affect millions globally, making the need for accurate and efficient recording systems crucial. The new Prucka 3 system is designed to address these needs and enable path to new technologies in the EP lab.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
-
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) will announce its Q4 and full year 2023 financial results on February 6, 2024. A live webcast and conference call will be hosted by the management team at 8:30 a.m. Eastern Time. The webcast replay and financial information will be available on the GE HealthCare Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
Rhea-AI Summary
GE HealthCare (GEHC) announced the acquisition of MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology. The acquisition aims to strengthen GE HealthCare's digital solutions across care pathways, reinforcing its commitment to integrating medical imaging products for more precise, connected, and efficient care across disease states.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
FAQ
What is the current stock price of GE HealthCare Technologies (GEHC)?
The current stock price of GE HealthCare Technologies (GEHC) is $82.44 as of November 22, 2024.
What is the market cap of GE HealthCare Technologies (GEHC)?
The market cap of GE HealthCare Technologies (GEHC) is approximately 36.9B.
What does GE HealthCare Technologies Inc. do?
GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.
What are the main business segments of GE HealthCare?
The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
How does GE HealthCare generate most of its revenue?
The company generates the majority of its revenue from the Imaging segment.
What recent advancements has GE HealthCare made?
GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.
Who are GE HealthCare's partners?
The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.
How does GE HealthCare ensure compliance?
GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.
What products does GE HealthCare offer?
GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.
What is GE HealthCare's commitment to the community?
The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.
How has GE HealthCare performed financially?
GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.
What is GE HealthCare's mission?
GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.
GE HealthCare Technologies Inc.
Nasdaq:GEHC
GEHC Rankings
GEHC Stock Data
36.94B
442.78M
3.09%
83.51%
1.81%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
United States of America
CHICAGO